The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation
- 31 August 2005
- journal article
- review article
- Published by Elsevier in Transplant Immunology
- Vol. 14 (3-4) , 203-206
- https://doi.org/10.1016/j.trim.2005.03.008
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemiasBlood, 2005
- The Protein Made from a Common Allele of KIR3DL1 (3DL1*004) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1The Journal of Immunology, 2003
- Reconstitution of NK cell receptor repertoire followingHLA-matched hematopoietic cell transplantationBlood, 2003
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell TransplantationBlood, 1999
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998
- Bone marrow transplantation across HLA barriers by increasing the number of transplanted cellsImmunology Today, 1995
- Human Natural Killer Cells: Origin, Clonality, Specificity, and ReceptorsPublished by Elsevier ,1993